Psychemedics Corporation
PMDI
$2.30
$0.062.68%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -10.92% | -11.16% | -11.98% | -12.18% | -12.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.92% | -11.16% | -11.98% | -12.18% | -12.45% |
| Cost of Revenue | -8.05% | -12.08% | -12.25% | -14.61% | -14.19% |
| Gross Profit | -15.59% | -9.65% | -11.52% | -8.02% | -9.46% |
| SG&A Expenses | -19.08% | 0.18% | 11.02% | 9.44% | 12.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.75% | -8.03% | -4.20% | -6.25% | -4.96% |
| Operating Income | 35.17% | -21.64% | -105.31% | -84.82% | -169.62% |
| Income Before Tax | 44.27% | -0.96% | -56.95% | -113.44% | -230.58% |
| Income Tax Expenses | -107.68% | -95.58% | 462.62% | 904.10% | 1,527.27% |
| Earnings from Continuing Operations | 55.20% | 23.15% | -140.58% | -195.82% | -283.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.20% | 23.15% | -140.58% | -195.82% | -283.21% |
| EBIT | 35.17% | -21.64% | -105.31% | -84.82% | -169.62% |
| EBITDA | 37.47% | -128.05% | -4,492.16% | -685.35% | -249.04% |
| EPS Basic | 55.70% | 24.45% | -136.55% | -190.31% | -276.49% |
| Normalized Basic EPS | 35.48% | -19.18% | -98.50% | -78.40% | -176.48% |
| EPS Diluted | 55.31% | 24.45% | -134.58% | -187.29% | -271.07% |
| Normalized Diluted EPS | 35.48% | -19.18% | -98.50% | -78.40% | -176.24% |
| Average Basic Shares Outstanding | 2.37% | 2.21% | 2.12% | 2.14% | 2.03% |
| Average Diluted Shares Outstanding | 2.37% | 2.21% | 2.12% | 2.14% | 1.78% |
| Dividend Per Share | -- | -100.00% | -100.00% | -100.00% | -75.00% |
| Payout Ratio | -- | 1.00% | 1.00% | 0.77% | 0.82% |